Brief: Eloxx Pharmaceuticals Announces First Patients Dosed In Phase 2B Exact Study Of Exaluren In Nonsense Mutation Alport Syndrome11/09/2026 13:06
Last trade - 00:00Last trade - 00:00Last trade - 00:00